Patients with negative lymph nodes, positive ER expression, less triple-negative, and more radiotherapy history are more likely to be diagnosed with PLC, which may be related to the longer survival time of these patients, and chemotherapy significantly reduces the probability of local recurrence of breast cancer (16, 17). The gene discussed is ESR1; the disease is breast carcinoma.